申请人:Seto Shigeki
公开号:US20050159409A1
公开(公告)日:2005-07-21
A novel fused bicyclic pyrimidine derivative or a salt thereof that acts as a tachykinin receptor antagonist and, in particular, as an NK1 receptor antagonist is represented by the following general formula (1):
wherein the rings A and B are each a benzene ring having 1 to 3 substituents (any adjacent two of which may be bound to one another to form a ring); the ring C is a nitrogen-containing ring; R is a hydrogen atom, a C
1
to C
6
alkyl group, a C
1
to C
6
alkylcarbonyl group, or a C
1
to C
6
alkylsulfonyl group; m is 1 or 2; and n is 2 or 3.
下列一种新型融合的双环嘧啶衍生物或其盐,可作为一种速激肽受体拮抗剂,尤其是作为一种NK1 受体拮抗剂,其通式如下(1)所示:其中,环A和环B分别为苯环,具有1至3个取代基(任何相邻两个取代基可结合在一起形成环);环C为含氮环;R为氢原子、C1至C6烷基、C1至C6烷基羰基基团或C1至C6烷基磺酰基团;m为1或2;n为2或3。